.jpg)
Jubilant Life Sciences reported a net profit of Rs 203.72 crore as compared to a net loss of Rs 105.88 crore for the quarter ended June 30, 2013. Its total income from operations has increased by 25.82% to Rs 1036.24 for the quarter under review from Rs 823.56 crore for the corresponding quarter of the previous year.
On the consolidated basis, the company has reported a net profit after taxes, minority interest and share of profit / (loss) of associates of Rs 4.28 crore for the quarter as compared to a net loss of Rs 52.62 crore for the same quarter in the previous year. Its total income from operations has increased by 8.38% at Rs 1473.13 crore for quarter under review as compared to Rs 1359.27 crore for the quarter ended June 30, 2013.
The promoters holding in the company stood at 54.02% while Institutions and Non-Institutions held 27.58% and 18.39% respectively.
The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 222.00 on 13-Jun-2014 and a 52 week low of Rs. 65.10 on 28-Aug-2013.
Last one week high and low of the scrip stood at Rs. 203.65 and Rs. 176.65 respectively. The current market cap of the company is Rs. 3201.55 crore.
The scrip opened at Rs. 199.00 and has touched a high and low of Rs. 203.65 and Rs. 186.75 respectively. So far 124734 shares were traded on the counter.
Jubilant Life Sciences is currently trading at Rs. 191.65, down by 4.50 points or 2.29% from its previous closing of Rs. 196.15 on the BSE.
.jpg)
No comments:
Post a Comment